HAWKINS INC. - 10-Q Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended December 31, 2010, representing the first nine months of fiscal year 2011 (ending April 3, 2011). Hawkins, Inc. is a distributor and manufacturer of bulk and specialty chemicals, operating through two reportable segments: Industrial and Water Treatment. The company is headquartered in Minneapolis, Minnesota, and primarily serves customers within the United States.
Key Financial Metrics
Revenue and Profitability (Nine Months Ended Dec 31, 2010):
- Sales: $215.7 million (up 8.3% from $199.2 million in the prior year).
- Gross Profit: $49.9 million (23.1% margin, down from 24.7% in the prior year).
- Operating Income: $29.5 million (down slightly from $29.8 million in the prior year).
- Net Income: $18.4 million (up slightly from $18.3 million in the prior year).
- Diluted EPS: $1.78 (compared to $1.78 in the prior year).
Liquidity and Balance Sheet:
- Cash and Cash Equivalents: $47.9 million (up from $18.8 million at the start of the fiscal year).
- Total Current Assets: $117.2 million.
- Total Current Liabilities: $26.7 million.
- Debt: The filing does not disclose any long-term debt or notes payable; the company appears to be debt-free.
- Shareholders' Equity: $136.9 million.
Cash Flow (Nine Months Ended Dec 31, 2010):
- Operating Cash Flow: $24.3 million (down from $29.7 million in the prior year due to working capital increases).
- Investing Cash Flow: $11.8 million provided (driven by net sales of investments).
- Financing Cash Flow: $7.0 million used (primarily for dividends).
- Capital Expenditures: $7.8 million.
Material Changes vs. Prior Period
Revenue Growth: Sales increased $16.5 million year-over-year, driven by higher selling prices and increased volume in both segments. The Industrial segment saw a 9.4% sales increase, while Water Treatment grew by 6.0%.
Margin Compression: Gross profit margins declined from 24.7% to 23.1%. This was primarily due to:
- LIFO Impact: An increase in the LIFO reserve reduced gross profit by $1.4 million in the current period, compared to a $9.1 million increase in the prior year caused by falling raw material costs.
- Competitive Pressure: Management cited competitive pricing pressures and higher operational costs.
Segment Performance: While the Industrial segment's operating income increased by $0.9 million, the Water Treatment segment's operating income decreased by $1.1 million due to investments in new facilities and personnel.
Outlook, Risks, and Unusual Items
Acquisition (Subsequent Event): On January 14, 2011, the company completed the acquisition of substantially all assets of Vertex Chemical Corporation for $25.5 million. Vertex manufactures sodium hypochlorite and distributes bulk chemicals. Management expects the acquisition to be accretive to earnings.
Guidance and Outlook: Management anticipates raw material costs to remain at current levels through the end of fiscal 2011. They expect continued competitive pricing pressure which may negatively impact margins. The company plans to continue investing in new branches for the Water Treatment segment.
Risks: The company is subject to the cyclical nature of commodity chemical prices. While they attempt to pass cost increases to customers, there is no assurance they can do so. The company does not currently hedge commodity purchases.
Discontinued Operations: The Pharmaceutical segment was sold in fiscal 2010. No income from discontinued operations was recorded in the current period.
Investor Verification Checklist
- LIFO Reserve Impact: Verify the sensitivity of gross margins to future raw material cost fluctuations, as the LIFO method significantly altered year-over-year comparisons.
- Vertex Integration: Monitor the integration of the Vertex acquisition and whether the projected accretion to earnings materializes in the next quarter.
- Working Capital Trends: Review the increase in trade receivables and inventory levels, which reduced operating cash flow despite net income growth.
- Competitive Pricing: Assess the sustainability of sales volume growth given the noted competitive pricing pressures in both segments.
- Capital Allocation: Confirm the use of the $25.5 million cash outlay for the Vertex acquisition and its impact on the company's liquidity position.